India approves Takeda dengue vaccine QDENGA for ages 4-60
India has approved its first-ever vaccine for dengue, a significant step in combating a disease that accounts for nearly one-third of the global burden. The Drug Controller General of India granted market authorization on Monday, July 20, 2026, for the vaccine QDENGA, developed by the Japanese biopharmaceutical company...
Verilumia